Eventide Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Eventide Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-23,967	Closed	-$11.8M	–	117
2015 Q1	$11.8M	Hold	23,967	–	–	0.89%	46
2014 Q4	$8.57M	Hold	23,967	–	–	0.94%	47
2014 Q3	$4.62M	Hold	23,967	–	–	0.65%	58
2014 Q2	$5.73M	Hold	23,967	–	–	0.78%	57
2014 Q1	$6.13M	Buy	23,967 +6,489	+37%	+$1.98M	0.95%	50
2013 Q4	$3.46M	Buy	+17,478	New	+$3.11M	1.07%	45

Other funds holding LUMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Eventide Asset Management's LUMO Position: Q2 2015 in Review

Eventide Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2015, closing a stake of 23,967 shares — an estimated $11.8M sold.

Eventide Asset Management first reported a position in LUMO in Q4 2013 and held it in 6 quarters. The position peaked at $11.8M in Q1 2015. 145 funds tracked by Wall St. Rank hold LUMO as of Q2 2015.

Eventide Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
Eventide Asset Management sold 23,967 Lumos Pharma, Inc. Common Stock shares in Q2 2015, an estimated $11.8M.
Eventide Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 6 quarters.
Eventide Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $11.8M in Q1 2015.
145 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2015.

Based on Eventide Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.